109 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34046157 | The danger of diazoxide in the neonatal intensive care unit. | 2021 | 1 |
2 | 32274651 | The use of diazoxide in the management of spontaneous hypoglycemia in patients with ESRD. | 2020 Aug | 1 |
3 | 34055813 | Persistent Hypoglycemia with Polycystic Kidneys: A Rare Combination - A Case Report. | 2020 Sep-Dec | 1 |
4 | 31218401 | Genotype and phenotype analysis of a cohort of patients with congenital hyperinsulinism based on DOPA-PET CT scanning. | 2019 Aug | 1 |
5 | 29618011 | Effects of Diazoxide-Mediated Insulin Suppression on Glucose and Lipid Metabolism in Nondiabetic Obese Men. | 2018 Jun 1 | 4 |
6 | 28115493 | Esculentin-2CHa(1-30) and its analogues: stability and mechanisms of insulinotropic action. | 2017 Mar | 1 |
7 | 28400489 | Diazoxide for Lowering Insulin Levels in Breast Cancer Patients. | 2017 Apr | 1 |
8 | 28507564 | Management of the hormonal syndrome of neuroendocrine tumors. | 2017 Apr 1 | 1 |
9 | 26878387 | Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer. | 2016 Feb 15 | 3 |
10 | 27603903 | Diazoxide in Children With Obesity After Hypothalamic-Pituitary Lesions: A Randomized, Placebo-Controlled Trial. | 2016 Dec | 1 |
11 | 26116696 | Human Insulinomas Show Distinct Patterns of Insulin Secretion In Vitro. | 2015 Oct | 1 |
12 | 26137438 | A major role of insulin in promoting obesity-associated adipose tissue inflammation. | 2015 Jul | 2 |
13 | 26392140 | Topical sulfonylurea as a novel therapy for hypertrichosis secondary to diazoxide, and potentially for other conditions with excess hair growth. | 2015 Dec | 1 |
14 | 23303986 | A pilot study: effects of decreasing serum insulin with diazoxide on vitamin D levels in obese women with polycystic ovary syndrome. | 2012 | 1 |
15 | 21378174 | Partial inhibition of insulin secretion results in glucose intolerance but not hyperglucagonemia. | 2011 Apr | 2 |
16 | 20028939 | Six months of diazoxide treatment at bedtime in newly diagnosed subjects with type 1 diabetes does not influence parameters of {beta}-cell function and autoimmunity but improves glycemic control. | 2010 Mar | 2 |
17 | 19218500 | Endothelial heparanase secretion after acute hypoinsulinemia is regulated by glucose and fatty acid. | 2009 Apr | 2 |
18 | 19623043 | Hyperinsulinemia predicts survival in a hyperglycemic mouse model of critical illness. | 2009 Sep | 1 |
19 | 18476985 | Weight loss in obese men by caloric restriction and high-dose diazoxide-mediated insulin suppression. | 2008 Dec | 4 |
20 | 17289040 | Lack of effect of short-term diazoxide administration on luteinizing hormone secretion in women with polycystic ovary syndrome. | 2007 Jul | 1 |
21 | 17360975 | Glucose-dependent modulation of insulin secretion and intracellular calcium ions by GKA50, a glucokinase activator. | 2007 Jun | 1 |
22 | 17559844 | Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity. | 2007 Oct | 1 |
23 | 17587399 | No effect of inhibition of insulin secretion by diazoxide on weight loss in hyperinsulinaemic obese subjects during an 8-week weight-loss diet. | 2007 Jul | 4 |
24 | 16475928 | Towards selective Kir6.2/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectives. | 2006 | 1 |
25 | 16527842 | Diphenylhydantoin suppresses glucose-induced insulin release by decreasing cytoplasmic H+ concentration in pancreatic islets. | 2006 Jun | 1 |
26 | 17296510 | Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences. | 2006 Dec | 1 |
27 | 15339745 | Mechanism, temporal patterns, and magnitudes of the metabolic responses to the KATP channel agonist diazoxide. | 2005 Jan | 3 |
28 | 15734853 | Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans. | 2005 Mar | 1 |
29 | 15811140 | Diazoxide-mediated insulin suppression in obese men: a dose-response study. | 2005 May | 10 |
30 | 16356235 | Bench-to-bedside review: Antidotal treatment of sulfonylurea-induced hypoglycaemia with octreotide. | 2005 | 1 |
31 | 14706058 | Nine weeks of bedtime diazoxide is well tolerated and improves beta-cell function in subjects with Type 2 diabetes. | 2004 Jan | 2 |
32 | 15220194 | Glucose- and interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets. | 2004 Jul | 1 |
33 | 15333483 | Temporary preservation of beta-cell function by diazoxide treatment in childhood type 1 diabetes. | 2004 Sep | 2 |
34 | 12865318 | Diazoxide attenuates glucose-induced defects in first-phase insulin release and pulsatile insulin secretion in human islets. | 2003 Aug | 5 |
35 | 12958175 | ATP-sensitive potassium channels induced in liver cells after transfection with insulin cDNA and the GLUT 2 transporter regulate glucose-stimulated insulin secretion. | 2003 Sep | 2 |
36 | 14660022 | Effects of the beta-carbolines, harmane and pinoline, on insulin secretion from isolated human islets of Langerhans. | 2003 Dec 15 | 1 |
37 | 11815454 | Triggering of insulin release by a combination of cAMP signal and nutrients: an ATP-sensitive K+ channel-independent phenomenon. | 2002 Feb | 1 |
38 | 12213059 | 6-Chloro-3-alkylamino-4H-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivatives potently and selectively activate ATP sensitive potassium channels of pancreatic beta-cells. | 2002 Sep 12 | 1 |
39 | 12414839 | BPDZ 154 activates adenosine 5'-triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism. | 2002 Nov | 1 |
40 | 12522324 | Improved beta cell function after short-term treatment with diazoxide in obese subjects with type 2 diabetes. | 2002 Dec | 1 |
41 | 11249067 | Characterization of secretory and morphologic properties of primary cultured endocrine cells from porcine pancreata. | 2001 Mar | 1 |
42 | 11078450 | Glucose-induced [Ca2+]i abnormalities in human pancreatic islets: important role of overstimulation. | 2000 Nov | 1 |
43 | 10050013 | Influence of nitric oxide modulators on cholinergically stimulated hormone release from mouse islets. | 1999 Mar 1 | 1 |
44 | 9473513 | Necessity of endogenous GTP derived from glucose-6-phosphate for insulin secretion augmented by glucose under protein kinase A activation. | 1998 Feb 4 | 1 |
45 | 9540027 | Induction of beta-cell rest in type 1 diabetes. Studies on the effects of octreotide and diazoxide. | 1998 Mar | 1 |
46 | 9626118 | Beneficial effect of diazoxide in obese hyperinsulinemic adults. | 1998 Jun | 2 |
47 | 9653515 | The nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester potentiates insulin secretion stimulated by glucose and L-arginine independently of its action on ATP-sensitive K+ channels. | 1998 Feb | 2 |
48 | 9724074 | Leptin levels in women with polycystic ovary syndrome before and after treatment with diazoxide. | 1998 Aug | 3 |
49 | 9727845 | Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria. | 1998 Aug | 1 |
50 | 9877233 | Evidence for nitric oxide mediated effects on islet hormone secretory phospholipase C signal transduction mechanisms. | 1998 Aug | 1 |